Home blood-collection device supplier Boston Microfluidics has secured LabCorp as an investor in a $17.5m round that was led by Anzu Partners.
US-based diagnostics technology manufacturer Boston Microfluidics has received $17.5m in a series A round led by venture capital firm Anzu Partners and backed by life sciences research services provider LabCorp.
Boston Microfluidics supplies blood collection devices that enable patients to take samples at home rather than relying on visits to a doctor’s surgery. LabCorp already offers Boston’s flagship product, Neotainer, as part of a consumer wellness testing service branded Pixel by LabCorp.
The series A cash will go to research…
